1-2 of 2
Nahal Lalefar
Close
Sort by
Journal Articles

Abatacept for GVHD prophylaxis can reduce racial disparities by abrogating the impact of mismatching in unrelated donor stem cell transplantation

Clinical Trials & Observations
Muna Qayed, Benjamin Watkins, Scott Gillespie, Brandi Bratrude, Kayla Betz, Sung W. Choi, Jeffrey Davis, Christine Duncan, Roger Giller, Michael Grimley, Andrew C. Harris, David Jacobsohn, Nahal Lalefar, Maxim Norkin, Nosha Farhadfar, Michael A. Pulsipher, Shalini Shenoy, Aleksandra Petrovic, Kirk R. Schultz, Gregory A. Yanik, Edmund K. Waller, Amelia Langston, Leslie S. Kean, John T. Horan
Journal: Blood Advances
Blood Adv (2022) 6 (3): 746–749.
https://doi.org/10.1182/bloodadvances.2021005208
Published: 2022
Includes: Supplemental data
Journal Articles

A pragmatic multi-institutional approach to understanding transplant-associated thrombotic microangiopathy after stem cell transplant

Clinical Trials & Observations
Christopher E. Dandoy, Seth Rotz, Priscila Badia Alonso, Anna Klunk, Catherine Desmond, John Huber, Hannah Ingraham, Christine Higham, Christopher C. Dvorak, Christine Duncan, Michelle Schoettler, Leslie Lehmann, Maria Cancio, James Killinger, Blachy Davila, Rachel Phelan, Kris M. Mahadeo, Sajad Khazal, Nahal Lalefar, Madhav Vissa, Kasiani Myers, Greg Wallace, Adam Nelson, Pooja Khandelwal, Deepika Bhatla, Nicholas Gloude, Eric Anderson, Jeffrey Huo, Philip Roehrs, Jeffery J. Auletta, Ranjit Chima, Adam Lane, Stella M. Davies, Sonata Jodele
Journal: Blood Advances
Blood Adv (2020) 5 (1): 1–11.
https://doi.org/10.1182/bloodadvances.2020003455
Published: 2020
Includes: Supplemental data